InflaRx Statistics
Share Statistics
InflaRx has 67.13M
shares outstanding. The number of shares has increased by 14.01%
in one year.
| Shares Outstanding | 67.13M |
| Shares Change (YoY) | 14.01% |
| Shares Change (QoQ) | 14.01% |
| Owned by Institutions (%) | 22.06% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 27,786 |
| FTD / Avg. Volume | 6.56% |
Short Selling Information
The latest short interest is 924.15K, so 1.38% of the outstanding
shares have been sold short.
| Short Interest | 924.15K |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 2.44 |
Valuation Ratios
The PE ratio is -3.05 and the forward
PE ratio is -2.33.
InflaRx's PEG ratio is
0.
| PE Ratio | -3.05 |
| Forward PE | -2.33 |
| PS Ratio | 847.69 |
| Forward PS | 0.6 |
| PB Ratio | 2.29 |
| P/FCF Ratio | -2.89 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for InflaRx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.06,
with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.06 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.02 |
| Interest Coverage | -2566.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $2,240.39 |
| Profits Per Employee | $-622,491.92 |
| Employee Count | 74 |
| Asset Turnover | 0 |
| Inventory Turnover | 0.48 |
Taxes
| Income Tax | 5.22K |
| Effective Tax Rate | -0.01% |
Stock Price Statistics
The stock price has increased by 31.67% in the
last 52 weeks. The beta is 1.59, so InflaRx's
price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | 31.67% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 58.66 |
| Average Volume (20 Days) | 423,473 |
Income Statement
In the last 12 months, InflaRx had revenue of 165.79K
and earned -46.06M
in profits. Earnings per share was -0.78.
| Revenue | 165.79K |
| Gross Profit | -3.15M |
| Operating Income | -53.01M |
| Net Income | -46.06M |
| EBITDA | -45.55M |
| EBIT | -46.04M |
| Earnings Per Share (EPS) | -0.78 |
Full Income StatementBalance Sheet
The company has 18.38M in cash and 805.09K in
debt, giving a net cash position of 17.57M.
| Cash & Cash Equivalents | 18.38M |
| Total Debt | 805.09K |
| Net Cash | 17.57M |
| Retained Earnings | -332.19M |
| Total Assets | 76.02M |
| Working Capital | 57.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -48.56M
and capital expenditures -46.87K, giving a free cash flow of -48.6M.
| Operating Cash Flow | -48.56M |
| Capital Expenditures | -46.87K |
| Free Cash Flow | -48.6M |
| FCF Per Share | -0.82 |
Full Cash Flow StatementMargins
Gross margin is -1900.76%, with operating and profit margins of -31973.69% and -27784.96%.
| Gross Margin | -1900.76% |
| Operating Margin | -31973.69% |
| Pretax Margin | -27781.81% |
| Profit Margin | -27784.96% |
| EBITDA Margin | -27476.74% |
| EBIT Margin | -31973.69% |
| FCF Margin | -29316.52% |
